首页 / 产品 / 抗体 / 一抗

Rabbit Polyclonal ZNF830 Antibody

  • 中文名: ZNF830抗体
  • 别    名: Zinc finger protein 830, Coiled-coil domain-containing protein 16, ZNF830, CCDC16
货号: IPDX32678
Price: ¥1180
数量:
大包装询价

验证与应用

应用及物种
WB 1/1000 Human,Mouse,Rat
IF 咨询技术 Human,Mouse,Rat
IHC 咨询技术 Human,Mouse,Rat
ICC 技术咨询 Human,Mouse,Rat
FCM 咨询技术 Human,Mouse,Rat
Elisa 咨询技术 Human,Mouse,Rat

产品详情

AliasesZinc finger protein 830, Coiled-coil domain-containing protein 16, ZNF830, CCDC16
Entrez GeneID91603
WB Predicted band size42.0kDa
Host/IsotypeRabbit IgG
Antibody TypePrimary antibody
StorageStore at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze/thaw cycles.
Species ReactivityHuman
ImmunogenThis ZNF830 antibody is generated from a rabbit immunized with a KLH conjugated synthetic peptide between 173-207 amino acids from the Central region of human ZNF830.

+ +

参考文献

以下是关于ZNF830抗体的3篇参考文献示例(注:以下内容为模拟,实际文献可能需要根据具体数据库检索补充):

---

1. **文献名称**: "ZNF830 mediates DNA damage repair by regulating homologous recombination"

**作者**: Li X, et al.

**摘要**: 本研究利用ZNF830特异性抗体(兔多克隆),通过免疫印迹和免疫荧光技术,发现ZNF830通过与RAD51相互作用促进同源重组修复。抗体验证显示其在敲除细胞系中无交叉反应。

2. **文献名称**: "Characterization of a novel monoclonal antibody against human ZNF830 for cancer biomarker studies"

**作者**: Wang Y, et al.

**摘要**: 文章报道了一种新型小鼠单克隆ZNF830抗体的开发,验证了其在ELISA、免疫组化中的特异性,并发现ZNF830在结直肠癌组织中高表达,与预后相关。

3. **文献名称**: "ZNF830 regulates cell cycle progression via p53 signaling pathway"

**作者**: Zhang R, et al.

**摘要**: 通过ZNF830抗体(货号AB123. Sigma)进行ChIP-seq分析,揭示ZNF830结合p53启动子区域调控细胞周期进程。抗体特异性通过siRNA敲低实验确认。

---

如需具体文献,建议通过PubMed或Google Scholar以关键词“ZNF830 antibody”、“ZNF830 immunohistochemistry”等进一步检索。

背景信息

The ZNF830 antibody is a research tool designed to detect and study the zinc finger protein 830 (ZNF830), a member of the zinc finger protein family characterized by conserved C2H2-type zinc finger domains. ZNF830 is implicated in DNA damage response pathways, particularly in homologous recombination repair, where it interacts with key proteins like BRCA1 to maintain genomic stability. Dysregulation of ZNF830 has been linked to cancer progression, especially in BRCA1-deficient malignancies, making it a potential biomarker or therapeutic target. The antibody is commonly used in techniques such as Western blotting, immunoprecipitation, and immunofluorescence to investigate ZNF830's expression patterns, subcellular localization, and protein-protein interactions. Most commercially available ZNF830 antibodies are produced in rabbit or mouse hosts, with validation in specific cell lines or tissues. Researchers utilize this reagent to explore ZNF830's role in DNA repair mechanisms, its involvement in carcinogenesis, and its relationship with cancer-associated pathways. Current studies focus on its diagnostic relevance in breast and ovarian cancers, as well as its functional crosstalk with other DNA repair factors. Proper validation of antibody specificity through knockout controls remains critical for reliable experimental outcomes.

客户数据及评论

折叠内容

大包装询价

×